Back to Results
First PageMeta Content
Health / Clinical pharmacology / Antidepressant / Pharmaceuticals policy / Medicaid / Psychopharmacology / Food and Drug Administration / Medical prescription / Prescription costs / Pharmacology / Pharmaceutical sciences / Medicine


POLICY OPTIONS SUBCOMMITTEE ON EVIDENC-BASED PRACTICES ON
Add to Reading List

Document Date: 2004-02-24 08:03:40

Open Document

File Size: 27,50 KB

Share Result on Facebook

Company

Medicaid / R&D Incentives State / Preserve Patient Choice / /

Event

Reorganization / /

IndustryTerm

treatment of mental disorders / treatment for mental disorders / insurance coverage / care for the most disabling mental disorders / health insurance plans / pharmaceutical agents / insurance plans / outpatient services / generic products / treatment of anxiety disorder / Health insurance programs / treatment of most mental disorders / /

MedicalCondition

mental disorder / anxiety disorder / schizophrenia / depression / refractory schizophrenia / mental disorders / /

MedicalTreatment

pharmacotherapies / /

Organization

FDA / POLICY OPTIONS SUBCOMMITTEE ON EVIDENC-BASED PRACTICES ON MENTAL HEALTH POLICY AND PSYCHOTROPIC DRUGS / Committee on Evidence-Based Practices / /

Technology

drug development / /

SocialTag